NCT01768871

Brief Summary

The primary objective of this study is to evaluate the function of the knee after a total knee replacement with the VEGA system®.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
7

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jan 2013

Typical duration for all trials

Geographic Reach
1 country

3 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2013

Completed
13 days until next milestone

First Submitted

Initial submission to the registry

January 14, 2013

Completed
2 days until next milestone

First Posted

Study publicly available on registry

January 16, 2013

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2015

Completed
Last Updated

November 14, 2018

Status Verified

November 1, 2018

Enrollment Period

2.5 years

First QC Date

January 14, 2013

Last Update Submit

November 12, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • WOMAC

    WOMAC function score 2 years post arthroplasty

    Two years

Secondary Outcomes (1)

  • Health related quality of life

    Two years

Eligibility Criteria

Age21 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients who have undergone a total knee arthroplasty with the VEGA knee system®

You may qualify if:

  • willing to sign the informed consent.
  • Patient has intact collateral ligaments.

You may not qualify if:

  • Inflammatory arthritis
  • Patients that have had a high tibial osteotomy or femoral osteotomy
  • Patients with neuromuscular or neurosensory deficiency which would make it difficult to assess the device performance.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Rose Medical Center

Denver, Colorado, 80220, United States

Location

DBA Hussamy Sports and Hand Center

Vero Beach, Florida, 32960, United States

Location

Charles J DePaolo, MD, PA

Asheville, North Carolina, 28801, United States

Location

Study Officials

  • Khaled Saleh

    Southern Illinois University School of Medicine

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 14, 2013

First Posted

January 16, 2013

Study Start

January 1, 2013

Primary Completion

July 1, 2015

Study Completion

July 1, 2015

Last Updated

November 14, 2018

Record last verified: 2018-11

Locations